3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Myelodysplastic Syndromes
8
Burkitt Lymphoma
5
Myeloproliferative Disorders
4
Primary Myelofibrosis
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Biphenotypic, Acute
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Ganglioneuroblastoma
2
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Polycythemia Vera
1
Neuroblastoma
1
Lymphoma, T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Prolymphocytic
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
fludarabine
4
fludarabine phosphate
3
asciminib
3
venetoclax
2
gilteritinib
2
Whole-Body Irradiation
2
Tacrolimus
2
Idarubicin
2
Cytarabine
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
ponatinib
1
nilotinib
1
enasidenib
1
blinatumomab
1
aldesleukin
1
Thiotepa
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Methotrexate
1
Mesna
1
Melphalan
1
Interleukin-2
1
Imatinib Mesylate
1
Hyperbaric Oxygenation
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Stem Cell Transplantation
×
90 days
×
Clear all
No trials found.